Chemed (NYSE:CHE) Reaches New 1-Year High – Time to Buy?

Chemed Corporation (NYSE:CHE) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $497.25 and last traded at $492.96, with a volume of 123949 shares. The stock had previously closed at $491.89.

Wall Street Analysts Forecast Growth

CHE has been the subject of a number of analyst reports. Royal Bank Of Canada boosted their price objective on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research report on Monday, April 27th. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Bank of America boosted their price target on shares of Chemed from $450.00 to $510.00 and gave the company a “neutral” rating in a report on Thursday, July 9th. Finally, Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a research report on Monday, June 8th. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $480.25.

Chemed Stock Up 0.2%

The firm has a market cap of $6.54 billion, a price-to-earnings ratio of 26.86, a price-to-earnings-growth ratio of 1.81 and a beta of 0.52. The stock’s 50 day moving average is $447.15 and its 200 day moving average is $429.88. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11.

Chemed (NYSE:CHE) last released its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. The firm had revenue of $657.51 million during the quarter, compared to the consensus estimate of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Analysts forecast that Chemed Corporation will post 22.67 EPS for the current year.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were issued a $0.60 dividend. The ex-dividend date was Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. Chemed’s dividend payout ratio is 13.08%.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director directly owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 3.33% of the company’s stock.

Hedge Funds Weigh In On Chemed

Large investors have recently made changes to their positions in the business. Monetary Solutions Ltd acquired a new position in shares of Chemed in the 4th quarter worth approximately $25,000. Los Angeles Capital Management LLC acquired a new stake in Chemed during the fourth quarter valued at approximately $26,000. BOK Financial Private Wealth Inc. bought a new stake in Chemed during the fourth quarter worth approximately $27,000. Versant Capital Management Inc boosted its holdings in Chemed by 7,500.0% during the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after buying an additional 75 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB boosted its holdings in Chemed by 65.3% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock worth $38,000 after buying an additional 32 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.